Acadia Pharmaceuticals (ACAD) Current Deferred Revenue (2010 - 2017)
Acadia Pharmaceuticals' (ACAD) quarterly Current Deferred Revenue came in at $4.1 million in Q1 2017, up 56.28% quarter-over-quarter from $2.6 million in Q4 2016.
Acadia Pharmaceuticals (ACAD) Current Deferred Revenue (2010 - 2017) Analysis & Trends
Acadia Pharmaceuticals' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $4.1 million for Q1 2017.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $4.1 million in Q1 2017; TTM through Mar 2017 was $4.1 million, a N/A change from a year earlier, with the FY2016 full-year figure at $2.6 million, changed N/A from the prior year.
- Current Deferred Revenue rose to $4.1 million in Q1 2017 per ACAD's latest filing, from $2.6 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $4.1 million in Q1 2017 and bottomed at $15000.0 in Q3 2014.
- The 4-year median for Current Deferred Revenue is $111000.0 (2013), against an average of $876090.9.
- Biggest YoY gain for Current Deferred Revenue was 69.92% in 2013; the steepest drop was 87.33% in 2013.
- Year by year, Current Deferred Revenue stood at $55000.0 in 2013, then sank by 72.73% to $15000.0 in 2014, then jumped by 17526.67% to $2.6 million in 2016, then jumped by 56.28% to $4.1 million in 2017.
- Per Business Quant, the three latest ACAD Current Deferred Revenue figures stand at $4.1 million (Q1 2017), $2.6 million (Q4 2016), and $1.9 million (Q3 2016).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 4.13 Mn |
| Dec 31, 2016 | 2.64 Mn |
| Sep 30, 2016 | 1.88 Mn |
| Jun 30, 2016 | 513,000.00 |
| Sep 30, 2014 | 15,000.00 |
| Jun 30, 2014 | 29,000.00 |
| Mar 31, 2014 | 42,000.00 |
| Dec 31, 2013 | 55,000.00 |
| Sep 30, 2013 | 80,000.00 |
| Jun 30, 2013 | 111,000.00 |
| Mar 31, 2013 | 140,000.00 |
| Dec 31, 2012 | 434,000.00 |
| Sep 30, 2012 | 266,000.00 |
| Jun 30, 2012 | 765,000.00 |
| Mar 31, 2012 | 683,000.00 |
| Dec 31, 2011 | 669,000.00 |
| Sep 30, 2011 | 708,000.00 |
| Jun 30, 2011 | 753,000.00 |
| Dec 31, 2010 | 690,000.00 |